Back to mobile site

Praxis Precision Medicines Inc. (PRAX) PT Raised to $550 at Jefferies

May 7, 2026 1:54 PM EDT Send to a Friend
Jefferies analyst Andrew Tsai raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $550.00 (from $525.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login